1. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study. Issue 8 (August 2017) Authors: Perl, Alexander E; Altman, Jessica K; Cortes, Jorge; Smith, Catherine; Litzow, Mark; Baer, Maria R; Claxton, David; Erba, Harry P; Gill, Stan; Goldberg, Stuart; Jurcic, Joseph G; Larson, Richard A; Liu, Chaofeng; Ritchie, Ellen; Schiller, Gary; Spira, Alexander I; Strickland, Stephen A; Tibes, Ra... Journal: Lancet oncology Issue: Volume 18:Issue 8(2017:Aug.) Page Start: 1061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia. Issue 2 (23rd November 2020) Authors: Zheng, Hong; Mineishi, Shin; Claxton, David; Zhu, Junjia; Zhao, Chenchen; Jia, Bei; Ehmann, W. Christopher; Rybka, Witold B.; Naik, Seema; Songdej, Natthapol; Drabick, Joseph J.; Hohl, Raymond J. Journal: American journal of hematology Issue: Volume 96:Issue 2(2021) Page Start: E46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Low-dose total body irradiation promotes T-cells donor chimerism in reduced-intensity/non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide. (December 2022) Authors: Shah, Neal; Cioccio, Joseph; Rakszawski, Kevin; Zheng, Hong; Nickolich, Myles; Naik, Seema; Wirk, Baldeep; Rybka, Witold; Ehmann, Christopher; Silar, Brook; Vajdic, Caitlin; Mierski, Joseph; Zhou, Shouhao; Shike, Hiroko; Greiner, Robert; Brown, Valerie; Hohl, Raymond; Claxton, David; Mineishi, Sh... Journal: Leukemia research Issue: Volume 123(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Therapy of acute myeloid leukemia: therapeutic targeting of tyrosine kinases. (3rd April 2019) Authors: Cioccio, Joseph; Claxton, David Journal: Expert opinion on investigational drugs Issue: Volume 28:Number 4(2019) Page Start: 337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SPEAK Out! Day with Future Teachers Taking the Lead. Issue 4 (4th May 2018) Authors: Watterson, Thomas; Wells, Gayle; Claxton, David; Grube, Dan Journal: Journal of physical education, recreation & dance Issue: Volume 89:Issue 4(2018) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IMPROVE-BMT: a protocol for a pilot randomised controlled trial of prehabilitation exercise for adult haematopoietic stem cell transplant recipients. Issue 1 (18th January 2023) Authors: Potiaumpai, Melanie; Schmitz, Kathryn H; Mineishi, Shin; Naik, Seema; Wirk, Baldeep; Rakszawski, Kevin; Ehmann, W Christopher; Claxton, David; Nickolich, Myles; Zemel, Babette S; Zheng, Hong Journal: BMJ open Issue: Volume 13:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clofarabine in the treatment of acute myeloid leukemia in older adults. (February 2013) Authors: Tiley, Stephen; Claxton, David Journal: Therapeutic advances in hematology Issue: Volume 4:Number 1(2013) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study. (21st September 2016) Authors: Kirschbaum, Mark H.; Frankel, Paul; Synold, Timothy W.; Zain, Jasmine; Claxton, David; Tuscano, Joseph; Newman, Edward M.; Gandara, David R.; Lara, Primo N. Journal: British journal of haematology Issue: Volume 180:Number 3(2018) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗